KFSH space medicine study lands in Altmetric top 5%

A King Faisal Specialist Hospital and Research Centre study with the Saudi Space Agency ranks among the top 5% of research worldwide for attention and engagement, according to Altmetric. The Science Advances paper examines how spaceflight changes human cell biology and could inform astronaut health, long-duration missions, and disease research on Earth. Why it matters: - The KFSH-Saudi Space Agency study is drawing attention well beyond academia. - The research may help explain how microgravity changes human cells and how those changes affect astronaut health. - The findings could also support better understanding of health conditions on Earth. - The study’s patent-pending platform may help predict drug effects and toxicity during drug development. What happened: - A study led by researchers at King Faisal Specialist Hospital and Research Centre, in collaboration with the Saudi Space Agency, ranked among the top 5% of research worldwide for attention and engagement on Altmetric. - The paper was published in Science Advances, the journal of the American Association for the Advancement of Science. - The study examined molecular changes in human cells aboard the International Space Station. - The work focused on gene expression and linked changes to molecular networks tied to human health. The details: - The research identified pathways enriched with genes affecting muscle and cardiac contraction, the neuronal system, and sensory perception. - The study also found changes in biological pathways linked to vision, sleep, movement, and DNA repair. - Altmetric tracks attention beyond citations, including media coverage, digital platforms, public policy documents, and research data sources. - Dr. Khalid Abu Khabar, KFSH research group leader and principal scientist, said the response reflects the study’s scientific and societal reach. - Abu Khabar said the work addresses a core space medicine question: how human cells respond to microgravity and what that means for astronaut safety and human health on Earth. - The KFSH-SSA platform is patent-pending and is designed to support drug development. Between the lines: - The ranking signals that space medicine research is gaining visibility as a practical health and technology field, not just a niche scientific topic. - The study’s Earth-health relevance broadens its value beyond space missions. - KFSH’s involvement also reinforces Saudi Arabia’s push to position itself as a contributor to global space and biomedical research. - In 2023, KFSH announced it was leading several cell science experiments in space as part of Saudi Arabia’s first scientific mission. - Saudi astronauts Rayyanah Barnawi and Ali Alqarni traveled to the International Space Station during that mission. - Barnawi, formerly a research assistant at KFSH, conducted the station experiments, while Dr. Widjan Alahamdi ran parallel experiments on Earth. - The Saudi Space Agency featured the study in a campaign highlighting Saudi research aboard the International Space Station. What’s next: - KFSH said it will continue expanding biomedical research in space medicine and human health. - Future studies are expected to examine how space environments affect body functions and diseases. - The work may help advance diagnostic and treatment methods for both spaceflight and Earth-based care. - KFSH also noted its broader recognition in 2026, including a No. 1 ranking in the Middle East and North Africa and No. 12 globally among Academic Medical Centers, plus brand and hospital-list honors from Brand Finance and Newsweek.